Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
作者信息
Shildt R, Stephens R L, Subramanian V P, Baker L H, Fletcher W S, O'Bryan R M, McCracken J D
出版信息
Cancer Treat Rep. 1985 Jun;69(6):709-10.
PMID:4016775
Abstract
摘要
相似文献
1
2
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.重氮醌用于胰腺癌的II期评估：西南肿瘤学组研究
Cancer Treat Rep. 1987 Dec;71(12):1309-10.
3
Phase II trial of diaziquone in advanced renal adenocarcinoma.
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1055-6.
4
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.重氮醌用于晚期软组织和骨肉瘤的II期研究：一项西南肿瘤协作组的研究
Cancer Treat Rep. 1985 Sep;69(9):1035-6.
5
6
Phase II study of diaziquone in patients with advanced carcinoma of the lung.重氮醌用于晚期肺癌患者的II期研究。
Cancer Treat Rep. 1984 Sep;68(9):1193-4.
7
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Cancer Treat Rep. 1986 May;70(5):671-2.
8
Phase II trial of diaziquone in advanced upper aerodigestive cancer.地吖醌用于晚期上消化道癌症的II期试验。
Cancer Treat Rep. 1985 Jan;69(1):141.
9
Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.重氮醌用于难治性和复发性多发性骨髓瘤患者的II期试验：一项西南肿瘤协作组研究
Cancer Treat Rep. 1987 Nov;71(11):1095-6.
10
Phase II clinical trial of diaziquone in bronchogenic carcinoma.
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.
Zotero 插件